Context Capital Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Context Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Context Capital Management from 13F filings

Historical chart of Context Capital Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Context Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.9B 2.0M 931.50
2023-09-30 $1.9M 2.0k 936.00

More positions owned by Context Capital Management

Peloton Interactive Note 2/1 (Principal)
Wayfair Note 1.000% 8/1 (Principal)
Wayfair Note 0.625%10/0 (Principal)
Coinbase Global Note 0.500% 6/0 (Principal)
Microstrategy Note 2/1 (Principal)
3d Sys Corp Del Note 11/1 (Principal)
Sea Note 0.250% 9/1 (Principal)
Travere Therapeutics Note 2.250% 3/0 (Principal)
Marathon Digital Holdings In Note 1.000%12/0 (Principal)
Xometry Note 1.000% 2/0 (Principal)
Microstrategy Note 0.750%12/1 (Principal)
Mannkind Corp Note 2.500% 3/0 (Principal)
Alphatec Hldgs Note 0.750% 8/0 (Principal)
Groupon Note 1.125% 3/1 (Principal)
Affirm Hldgs Note 11/1 (Principal)

View all positions for Context Capital Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
SSI Investment Management
CSS
Readystate Asset Management
CNH Partners

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1